Journal Article Summary
The article investigates the effectiveness of various drug therapies for treating cerebral infarction (CI), a common type of ischemic stroke that can lead to significant disability and mortality. Given the rising incidence of CI and its impact on public health, understanding which treatments are most effective is crucial for improving patient outcomes. The study specifically compares seven different drug therapies, including combinations of aspirin with other medications, to determine which offers the best balance of efficacy and safety.
The researchers conducted a network meta-analysis, reviewing data from 13 randomized controlled trials that included a total of 16,771 patients with CI. They found that the combination of aspirin and dipyridamole was associated with lower mortality rates compared to aspirin plus clopidogrel, suggesting it may be a more effective treatment option. However, there were no significant differences in rates of intracranial hemorrhage, stroke recurrence, or adverse events among the seven therapies studied. The analysis ranked aspirin plus dipyridamole as the most effective treatment based on its surface under the cumulative ranking curves (SUCRA) values.
Despite the findings, the study has limitations, including a relatively small number of trials and a focus on specific populations from Europe, America, and Asia, which may not represent all patients with CI. Patients should consult their healthcare providers to discuss these findings and consider their individual health circumstances when making treatment decisions. It is important to weigh the benefits and risks of different therapies, especially since some combinations may lead to higher rates of adverse effects.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Zhang Jian-Jun, Liu Xin. Aspirin plus dipyridamole has the highest surface under the cumulative ranking curves (SUCRA) values in terms of mortality, intracranial hemorrhage, and adverse event rate among 7 drug therapies in the treatment of cerebral infarction. Medicine 2018. DOI: 10.1097/MD.0000000000010123. PMID: 29595635. PMCID: PMC5895377.
Featured Pill Pals Product
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs --- Over The Counter
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over — Generic For Bayer Low Dose — Time Cap Labs — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
